Scope of the Journal
The Journal of Drug Resistant Pathogen Research publishes high-impact work on resistance mechanisms, pathogen evolution, novel therapeutics, diagnostics, surveillance, and stewardship. We welcome studies from clinical microbiology, infectious disease medicine, pharmacology, molecular biology, epidemiology, veterinary science, and public health.
Submissions should demonstrate rigorous methodology and clear relevance to the prevention, detection, or treatment of drug-resistant infections. Interdisciplinary studies that connect basic science to clinical application are strongly encouraged.
Priority Research Themes
We are particularly interested in manuscripts that address urgent AMR challenges and translate into actionable insights for clinical care and policy.
Resistance Mechanisms
Genetic and phenotypic pathways driving resistance, including horizontal gene transfer, efflux systems, and biofilm persistence.
Novel Therapeutics
New antibiotics, adjuvants, phage therapies, antimicrobial peptides, and combination strategies that address MDR and XDR pathogens.
Rapid Diagnostics
Innovations in rapid pathogen detection, susceptibility testing, and genomic surveillance for clinical and public health use.
Stewardship and Policy
Programs, interventions, and outcomes that reduce resistance and improve antimicrobial use.
Why Publish with JDRPR
Our editorial board includes leading experts in AMR, infectious diseases, and clinical microbiology. We provide fair peer review, clear communication, and open access distribution to ensure your findings reach researchers, clinicians, and decision-makers quickly.
Rigorous Review
Specialist reviewers evaluate methodology and clinical relevance
- Scope and ethics screening
- Subject-matter peer review
- Integrity and data checks
- Clear decision rationale
Global Visibility
Open access visibility across clinical and academic networks
- Immediate online publication
- Search engine discovery
- Shareable licensing
- Long-term access
Author Support
Editorial coordination to keep projects on track
- Pre-submission guidance
- Revision support
- Transparent timelines
- Professional production
Article Types
We publish original research, systematic reviews, short communications, methods papers, surveillance reports, and perspectives that advance understanding of drug-resistant pathogens.
Transparency
Include data availability statements and disclose any conflicts of interest.
Reproducibility
Provide detailed methods and validated diagnostics or assays.
Clinical Impact
Explain how findings affect treatment, stewardship, or surveillance.
Peer Review Timeline
We aim for rapid initial assessment and timely decisions while maintaining rigorous standards. Reviewers are selected based on domain expertise to ensure technically accurate and clinically relevant feedback.
Initial Check
Scope, ethics, and completeness review
Expert Review
Two or more specialist reviewers evaluate the manuscript
Decision
Clear editorial feedback and guidance for revisions
Publication
Accepted articles released open access with full metadata
Two Submission Methods
We offer two convenient submission routes to match your workflow preferences.
ManuscriptZone
Full-featured submission and tracking with reviewer communication tools.
What Makes a Strong Submission
Strong manuscripts present clear novelty, validated methods, and evidence that supports clinical or public health relevance. For resistance studies, describe the diagnostic approach, resistance criteria, and the clinical or epidemiological implications of the findings.
For therapeutic or diagnostic innovations, include validation against current standards of care and describe limitations transparently. Submissions with clear data availability statements and well documented methods are prioritized for efficient review.
Ethics and Transparency
All submissions must disclose funding sources, conflicts of interest, and ethical approvals where applicable. Clinical studies should describe consent procedures, cohort selection, and data privacy safeguards. Transparent reporting builds trust and improves review quality.
Submission Readiness Checklist
Before submitting, ensure your manuscript meets these essentials: a focused abstract, complete methods, labeled figures and tables, data availability statement, and references with DOIs when available. A concise cover letter that explains novelty and scope alignment helps editors select appropriate reviewers quickly.
Emerging Topics We Encourage
We welcome research on AMR in resource-limited settings, novel surveillance models, pathogen-host interactions that influence resistance, and implementation science that improves stewardship at scale. Studies that integrate genomics with clinical outcomes or link laboratory evidence to policy impact are especially valuable.
Submission Timing and Support
Submitting early allows more time for peer review and revisions, improving the likelihood of publication within planned issue windows. If you have questions about fit, send a brief abstract to the editorial office for guidance.
Interdisciplinary and Translational Work
We encourage submissions that connect laboratory discoveries with clinical implementation, such as studies linking resistance mechanisms to patient outcomes, diagnostics to stewardship impact, or surveillance data to policy change. Translational and implementation science that improves treatment decisions and infection control is especially valuable.
Rapid Communication Opportunities
Short communications that report time-sensitive findings, outbreak data, or early diagnostic results are welcome when supported by robust evidence. Clearly state the urgency and public health relevance in the abstract to help editors prioritize review.
Formatting Expectations
Ensure methods are detailed, figures are labeled, and data availability statements are included. Clear formatting speeds review and improves the chance of timely publication.
Regional and Global Relevance
We value studies that connect local resistance trends with global implications. Manuscripts that compare settings, describe surveillance networks, or propose scalable interventions help readers translate findings into action.
Share Your AMR Breakthroughs
Help shape the global response to drug-resistant infections with high-impact, open access publishing.